April 28, 2017
Recommended Topic Related To:

Vayarin

"The US Food and Drug Administration (FDA) has approved a chewable tablet form of extended-release methylphenidate (QuilliChew ER, Pfizer Inc) for attention-deficit/hyperactivity disorder (ADHD) in children aged 6 years and older, the compa"...

A A A

Vayarin

Vayarin®

DRUG DESCRIPTION

Vayarin® is an orally administered prescription medical food for the clinical dietary management of certain lipiid imbalances associated with ADHD in children.

Each capsule contains Lipirinen™ 167 mg, providing:

Phosphatidylserine (PS).................................................... 75 mg
Eicosapentaenoic acid fEPA) ........................................ 21.5 mg
Docosahexaenoic acid (DHA).......................................... 8.5 mg

Chemical Structure*

Vayarin - Structural Formula Illustration

* Schematic structure of one of the most abundant molecules present in Vayarin®.

Ingredients

Phosphatidylserine, Hyp rom el lose, Silicon Dioxide, Rosemary Extract (preservative), Mixed Tocopherols {E306-E309}, Ascorbyl Palmitate {E304)r Titanium Dioxide {color), Caramel (color).

Vayarin® capsules contain shellfish (krill).

May contain soy and fish.

Vayarin® capsules do not contain sugar lactose, yeast or gluten.

Pharmacology

Vayarin® is composed of Lipirinen™, a proprietary composition containing phosphatidyl serine-omega-3, EPA enriched.

Last reviewed on RxList: 11/23/2015
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.